Ingalls & Snyder LLC Portfolio Holdings

Ingalls & Snyder LLC

  • $2.33 Billion
  • Q2 2024

Ingalls & Snyder LLC has filed its 13F form on July 31, 2024 for Q2 2024 where it was disclosed a total value porftolio of $2.33 Billion distributed in 436 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Corcept Therapeutics Inc with a value of $268M, Exxon Mobil Corp with a value of $106M, Microsoft Corp with a value of $98.1M, Canadian Natural Resources LTD with a value of $95.6M, and Apple Inc. with a value of $92.8M.

Examining the 13F form we can see an increase of $61.2M in the current position value, from $2.26B to 2.33B.

Ingalls & Snyder LLC is based out at New York, NY

Below you can find more details about Ingalls & Snyder LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.33 Billion
Healthcare: $484 Million
Energy: $355 Million
Technology: $328 Million
Financial Services: $297 Million
Industrials: $192 Million
Communication Services: $169 Million
Consumer Cyclical: $142 Million
Basic Materials: $102 Million
Other: $208 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$7.23B
$1.11 Million 0.05% of portfolio
25,276
Q2 2024 Added 9.84%
Gsk PLC
-
$1.08 Million 0.05% of portfolio
-
Q2 2024 Reduced 2.23%
$5.74B
$1.1 Million 0.05% of portfolio
29,488
Q2 2024 Reduced 34.92%
$23B
$1.21 Million 0.05% of portfolio
3,305
Q2 2024 Reduced 0.9%
Noble Corp PLC
-
$1.07 Million 0.05% of portfolio
-
Q2 2024 Added 22.56%
$643M
$1.07 Million 0.05% of portfolio
200,000
Q1 2024 New
$0
$1.1 Million 0.05% of portfolio
6,018
Q2 2024 Added 0.25%
$116B
$1.22 Million 0.05% of portfolio
10,867
Q2 2024 Reduced 2.98%
$0
$1.06 Million 0.05% of portfolio
18,955
Q2 2024 Added 5.66%
$6.95B
$1.1 Million 0.05% of portfolio
25,344
Q1 2024 Added 322.4%
$334B
$973,000 0.04% of portfolio
951
Q2 2024 Reduced 0.94%
Bunge Global Sa
-
$976,000 0.04% of portfolio
-
Q2 2024 Reduced 1.08%
$84B
$825,000 0.04% of portfolio
4,120
Q2 2024 Reduced 0.17%
$5.57B
$966,000 0.04% of portfolio
38,485
Q2 2024 Added 3.43%
$2.03B
$992,000 0.04% of portfolio
285,000
Q1 2023 New
$2.04B
$960,000 0.04% of portfolio
20,931
Q1 2024 Reduced 0.85%
$58B
$1.04 Million 0.04% of portfolio
17,387
Q3 2023 Reduced 1.51%
$187B
$827,000 0.04% of portfolio
8,160
Q2 2024 Added 0.06%
$145B
$817,000 0.04% of portfolio
16,845
Q4 2023 Reduced 2.6%
Star Hldgs
-
$833,000 0.04% of portfolio
-
Q4 2023 Reduced 0.36%
$823B
$878,000 0.04% of portfolio
4,438
Q2 2024 Reduced 8.48%
$14.4B
$852,000 0.04% of portfolio
9,457
Q2 2024 Reduced 19.13%
$97.9B
$842,000 0.04% of portfolio
6,151
Q2 2024 Reduced 5.79%
$20.3B
$1.01 Million 0.04% of portfolio
135,084
Q2 2024 Added 224.0%
$0
$948,000 0.04% of portfolio
1,645
Q2 2023 Reduced 1.2%
$117B
$981,000 0.04% of portfolio
2,800
Q4 2021 Added 300.0%
$37.2B
$871,000 0.04% of portfolio
13,321
Q2 2024 Reduced 1.54%
$12.9B
$843,000 0.04% of portfolio
24,520
Q2 2024 Reduced 5.76%
$80.2B
$855,000 0.04% of portfolio
6,778
Q2 2024 Reduced 4.17%
$70.4M
$827,000 0.04% of portfolio
2,135,125
Q2 2023 Reduced 1.56%
$33.9B
$1.01 Million 0.04% of portfolio
11,280
Q2 2024 Reduced 17.26%
$41.2B
$948,000 0.04% of portfolio
10,259
Q2 2024 Reduced 2.38%
-
$618,000 0.03% of portfolio
-
Q1 2024 Reduced 22.72%
$67.3B
$767,000 0.03% of portfolio
12,165
Q2 2024 Reduced 0.77%
$16.9B
$667,000 0.03% of portfolio
13,497
Q2 2024 Reduced 0.58%
$3.67B
$652,000 0.03% of portfolio
29,340
Q3 2023 Reduced 21.42%
$27.1B
$590,000 0.03% of portfolio
3,270
Q4 2023 Reduced 5.44%
$14B
$686,000 0.03% of portfolio
23,821
Q4 2023 Reduced 0.83%
$60B
$746,000 0.03% of portfolio
15,802
Q2 2024 Reduced 0.32%
$47.6B
$605,000 0.03% of portfolio
12,347
Q2 2024 Reduced 6.77%
$0
$730,000 0.03% of portfolio
79,450
Q2 2024 Reduced 0.69%
$8.62B
$662,000 0.03% of portfolio
11,248
Q2 2024 Reduced 1.46%
$15.1B
$720,000 0.03% of portfolio
27,100
Q2 2024 Added 68.32%
$0
$638,000 0.03% of portfolio
1,165
Q1 2024 Reduced 9.34%
Esperion Therapeutics Inc Ne
-
$813,000 0.03% of portfolio
-
Q1 2024 Reduced 5.36%
-
$799,000 0.03% of portfolio
-
Q4 2023 Reduced 27.46%
$0
$679,000 0.03% of portfolio
2,173
Q2 2024 Added 3.38%
$0
$586,000 0.03% of portfolio
3,568
Q2 2024 Added 3.72%
$20.8B
$599,000 0.03% of portfolio
12,171
Q2 2024 Reduced 1.2%

Summary

  • Portfolio
  • No. of Stocks 436
  • Current Value $2.33 Billion
  • Prior Value $2.26 Billion
  • Filing
  • Period Q2 2024
  • Filing Date July 31, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 13 stocks
  • Additional Purchases 102 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 190 stocks
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email